Results 161 to 170 of about 3,901 (215)

Enzymatic synthesis of bioactive quinolones and (thio)coumarins by fungal type III polyketide synthases

open access: yesThe FEBS Journal, EarlyView.
Quinolones are valuable scaffolds for drug discovery but are rare in nature. Here, we show that two fungal enzymes, AthePKS and FerePKS, can generate 2‐quinolones and two additional heteroaromatic scaffolds. Using AthePKS, we designed an artificial enzymatic cascade towards an antimicrobial quinolone from a simple precursor and implemented it in E ...
Nika Sokolova   +5 more
wiley   +1 more source

Bioinspired twist-hyperbolic metamaterial for impact buffering and self-powered real-time sensing in UAVs. [PDF]

open access: yesSci Adv
Chao X   +11 more
europepmc   +1 more source

Deciphering the properties and reaction mechanism of anhydromevalonate phosphate decarboxylase, a prenylated flavin mononucleotide‐dependent enzyme in the archaeal mevalonate pathway

open access: yesThe FEBS Journal, EarlyView.
Characterization of anhydromevalonate phosphate decarboxylase, the UbiD‐family decarboxylase involved in the archaeal mevalonate pathway, was conducted. The enzyme is responsible for the biosynthesis of isoprenoids, such as archaeal membrane lipids, respiratory quinones, and dolichols.
Rino Ishikawa   +9 more
wiley   +1 more source

Are We Conflating Innovation Resistance With Innovation (Non‐)Adoption? A Reflection and Potential Resolution

open access: yesJournal of Product Innovation Management, EarlyView.
ABSTRACT Academic Summary In the realm of innovation studies, examining innovation responses—encompassing both adoption and resistance—has been a central focus for more than six decades. However, most innovation studies only focus on the behavioral dimension of these responses and simply equate resistance with non‐adoption.
Juliëtte van Acker   +4 more
wiley   +1 more source

S100PBP interacts with nucleoporin TPR and facilitates XY crossover formation in mice. [PDF]

open access: yesEMBO Rep
Wu Y   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy